Skip to content

Prevention of malnutrition and sarcopenia in aging people with proteindrinks

Prevention of malnutrition and sarcopenia in aging people with proteindrinks

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012273
Enrollment
80
Registered
2017-05-24
Start date
2017-04-06
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acceptance of a protein drink of older people that was designed regarding the physiological requirements and taste preferences of older people. Effect of the regular consumption of the drink on protein intake and dietary habits.

Interventions

Group 1: Older people (75 to 85 years) Investigation of the acceptance of a protein drink of older people and the effect of a regular consumption on dietary habits and protein intake with questionnai

Sponsors

Lehrstuhl für Ernährungsmedizin der Technischen Universität München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
75 Years to 85 Years

Inclusion criteria

Inclusion criteria: 75 - 85 years, willingness to participate, no guardianship, live in private household, able to get to the study centre, caucasian

Exclusion criteria

Exclusion criteria: current participation in an intervention study, smoker, chronic infection, chronic liver disease, diagnosed diabetes mellitus, untreatet endocrine disease, diagnosed autoimmune disease, diagnosed myocardial infarction within the last 3 years, diagnosed stroke within the last 3 years, pacemaker, untreatet hypertension >150/95 mmHg, diagnosed coronary cardiopathy within the last 3 years, cancer within the last 3 years, kidney disease requiring dialysis, Parkinson disease, liver disease, stomach ulcer, chronic lung disease with oxygen supply, circulatory disorder in the legs, diagnosed mental illness or neuroleptic desease within the last 3 years, immobile (chairbound), nursing case, unintentionally loss in weight >5% in the last 3 month, blood transfusion in the last 3 month, lactose intolerance, fructose intolerance, milk protein allergy, allergy against seafood, fish or crustaceans, vegan or vegetarian diet

Design outcomes

Primary

MeasureTime frame
Acceptance of the newly developed protein drink in comparison to an existing protein drink with a questionnaire after each studyphase (2 weeks) and with a diary (Daily intake oft the proteindrink)

Secondary

MeasureTime frame
Impact on protein intake and protein consumption patterns with 3-day-dietary-protocoll before baseline and in the second week of the two studyphases

Countries

Germany

Contacts

Public ContactAlexandra Tölke

Institut für Biomedizin des Alterns

alexandra.toelke@fau.de0911/5302-96165

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026